We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
7
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Completed
100.0%
No approval data available
- A groundbreaking study published in The New England Journal of Medicine demonstrates that ulipristal acetate, the active ingredient in ella emergency contraception, can effectively induce abortions with a 97% success rate. - Researchers administered 60mg doses of ulipristal acetate combined with misoprostol to 133 pregnant women, achieving comparable effectiveness to the FDA-approved abortion pill mifepristone. - The findings challenge current marketing claims by pharmaceutical companies that ella only prevents pregnancy and cannot terminate existing pregnancies.
